Skip to main content
SpringerLink
Log in

Oncogene overexpression in non-small-cell lung cancer tissue prevalence and clinicopathological significance

  • Molecular Medicine
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

Summary

In contrast to small-cell lung cancer, few data are available on the role of oncogene overexpression in non-small-cell lung cancers (NSCLC). To determine the prevalence and extent of the transcriptional activation of cancer genes in NSCLC we investigated the level of mRNA of the three important cellular oncogenes — erbB2, Ki-ras, and c-myc — in 39 surgically or endoscopically obtained tumor samples and 24 samples of normal bronchopulmonary tissue taken from the same patients. Tissue RNA was prepared and the specific mRNA analyzed by the highly sensitive nuclease S1 protection assay. Oncogene mRNA in the tumors was quantified by comparison with the homogeneously weak signals in normal lung tissue preparations with densitometry. The presence of two- to four-fold excess RNA was defined as moderate and a greater than fourfold RNA amount as strong gene overexpression. In contrast to normal tissue the oncogene mRNA amount varied considerably among tumors, showing increases up to 64-fold in erbB2, 13-fold in Ki-ras, and 57-fold in c-myc. Moderate and strong (in brackets) mRNA overexpression occurred with 33% (33%) in erbB2, 36% (18%) in Ki-ras, and 18% (23%) in c-myc. Simultaneous overexpression of two genes was observed with 41 % and increased mRNA of all genes tested with 20% of the NSCLC samples. Augmented oncogene mRNA was observed most frequently in large-cell carcinoma. The c-myc overexpression was significantly more prevalent in large-cell cancer than in adenocarcinoma. Tumor differentiation was negatively correlated with c-myc mRNA amounts. This correlation was highly significant. The Ki-ras and c-myc over-expression was rare in the small subpopulation of seven nonsmokers, although high erbB2 mRNA levels were observed in all but one patient. Oncogene overexpression is a common phenomenon in clinical tissue specimens taken from NSCLC. This further emphasizes their role in the maintenance of the malignant phenotype in established tumors. The c-myc overexpression correlates with the loss of cell differentiation and may further correlate with the tumor stage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

NSCLC:

non-small-cell lung cancer

SCLC:

small-cell lung cancer

References

  1. Alitalo K, Schwab M, Lin CC, Varmus HE, Bishop JM (1983) Amplification and aberrant expression of cellular oncogenes in human colon cancer. In: Bishop JM, Graves J, Rowley J (eds) Genes and cancer. Liss, New York, pp 383–387

    Google Scholar 

  2. Amstad P, Reddel RR, Pfeifer A, Malan-Shibley L, Mark GE, Harris CC (1988) Neoplastic transformation of a human bronchial epithelial cell line by a recombinant retrovirus encoding viral Harvey ras. Mol Carcinog 1:151–160

    Article  CAS  PubMed  Google Scholar 

  3. Balmain A, Ramsden M, Bowden GT, Smith J (1984) Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas. Nature 307:658–660

    Article  CAS  PubMed  Google Scholar 

  4. Berk AJ, Sharp PA (1977) Signing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids. Cell 12:721–728

    Article  CAS  PubMed  Google Scholar 

  5. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 162:156–159

    Article  CAS  PubMed  Google Scholar 

  6. Cline MJ, Battifora H (1987) Abnormalities of protooncogenes in non small lung cancer. Correlations with tumor type and clinical characteristics. Cancer 60:2669–2674

    Article  CAS  PubMed  Google Scholar 

  7. Ellis RW, De Feo D, Shih DY, Gonda MA, Young HA, Tsuchida N, Lowy DR, Scolnick EM (1981) The p 21 src genes of Harvey and Kirsten sarcoma viruses originate from different members of a family of normal vertebrate genes. Nature 292:506–511

    Article  CAS  PubMed  Google Scholar 

  8. Gazdar AF, Carney DN, Nau MM, Minna JD (1985) Characterization of variant subclasses of cells derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties. Cancer Res 45:2924–2930

    CAS  PubMed  Google Scholar 

  9. Hynes NE (1993) Amplification and overexpression of the erbB-2 gene in human tumors: its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy. Semin Cancer Biol 4:19–26

    CAS  PubMed  Google Scholar 

  10. Johnson BE, Battey J, Linnoila I, Becker KL, Makuch RW, Snider RH, Carney DN, Minna JD (1986) Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene. J Clin Invest 79:1629–1634

    Article  Google Scholar 

  11. Johnson BE, Ihde DC, Makuch RW, Gazdar AF, Carney DN, Oie H, Russell E, Nau MM, Minna JD (1987) myc family oncogene amplification in tumour cell lines established from small cell lung cancer patients and its relationship to clinical status and course. J Clin Invest 79:1629–1634

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kaul K (1988) Oncogenes in human lung cancer. In: Rosen ST, Mulshine JL, Cuttitta F, Abrams PG (eds) Biology of lung cancer. Diagnosis and treatment. Dekker, New York, pp 155–182

    Google Scholar 

  13. Kaye FJ (1990) Lung cancer. In: Cossman J (ed) Molecular genetics in cancer diagnostics. Elsevier, Amsterdam New York, pp 431–442

    Google Scholar 

  14. Kern JA, Schwartz DA, Nordberg JE, Weiner DB, Greene MI, Torney I, Robinson RA (1990) p185neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res 50:5184–5187

    CAS  PubMed  Google Scholar 

  15. Kiefer PE, Bepler G, Kubasch M, Bacher M, Havemann K (1987) Proto-oncogene expression in established lung cancer cell lines. J Cancer Res Clin Oncol [Suppl] 113:30

    Google Scholar 

  16. Kiefer PE, Wegmann P, Bacher M, Erbil C, Heidtmann H, Havemann K (1990) Different pattern of expression of cellular oncogenes in human non-small-cell lung cancer cell lines. J Cancer Res Clin Oncol 116:29–37

    Article  CAS  PubMed  Google Scholar 

  17. Little CD, Nau MM, Carney DN, Gazdar AF, Minna JD (1983) Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature 302:1022–1024

    Google Scholar 

  18. Marcu KB, Bossone SA, Patel AJ (1992) myc function and regulation. Annu Rev Biochem 61:809–860

    Article  CAS  PubMed  Google Scholar 

  19. Milburn MV, Tong L; De Vos AM, Brünger A, Yamaizumi Z, Nishimura S, Kim SH (1990) Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenec ras proteins. Science 247:939–946

    Article  CAS  PubMed  Google Scholar 

  20. Mountain CF (1986) A new international staging system for lung cancer. Chest [Suppl] 89:225–233

    Article  Google Scholar 

  21. Pfeifer A, Mark GE, Malan-Shibley GL, Graziano SL, Amstad P, Harris CC (1989) Cooperation of c-raf-1 and c-myc protooncogenes in the neoplastic transformation of SV40 T-antigen immortalized human bronchial epithelial cells. Proc Natl Acad Sci USA 86:10075–10079

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Pfeifer A, Jones RT, Bowden PE, Mann D, Spillare E, Klein-Szanto AJP, Trump BF, Harris CC (1991) Human bronchial epithelial cells transformed by the c-raf-1 and c-myc protooncogenes induce multidifferentiated carcinomas in nude mice: a model for lung carcinogenesis. Cancer Res 51:3793–3801

    CAS  PubMed  Google Scholar 

  23. Pfeifer-Ohlson S, Goustin AS, Rydnert J, Wahlström T, Bjersing L, Stehelin D, Ohlsson R (1984) Spatial and temporal pattern of cellular myc-oncogene expression in human placenta: implications for embryonic cell proliferation. Cell 38:585–596

    Article  Google Scholar 

  24. Reddel RR, Ke Y, Kaighn ME, Malan-Shibley L, Lechner JF, Rhim JS, Harris CC (1988) Human bronchial epithelial cells neoplastically transformed by v-Ki-ras: altered response to inducers of terminal squamous differentiation. Oncogene Res 3:401–408

    CAS  PubMed  Google Scholar 

  25. Rodenhuis S, van der Wetering ML, Moot WJ, Evers SG, van Zandwijk N, Bos JL (1987) Mutational activation of the K-ras oncogene: a possible pathogenic factor in adenocarcinoma of the lung. N Engl J Med 317:929–935

    Article  CAS  PubMed  Google Scholar 

  26. Schechter AL, Stern DF, Vaidyanathan L, Decker SJ, Drebin JA, Greene MJ, Weinberg RA (1984) The neu oncogene: an erbB-related gene encoding a 185000-M r tumor antigen. Nature 307:513–516

    Article  Google Scholar 

  27. Schwab M (1990) The role of gene dosage in the progression of tumors. In: Habenicht A (ed) Growth factors, differentiation factors and cytokines. Springer, Berlin Heidelberg New York, pp 345–355

    Google Scholar 

  28. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER2/neu oncogene. Science 235:177–182

    Article  CAS  PubMed  Google Scholar 

  29. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart ST, Udove J, Ullrich A, Press MF (1989) Studies of the HER-2/neu protooncogene in human breast and ovarian cancer. Science 244:707–712

    Article  CAS  PubMed  Google Scholar 

  30. Slebos RJ, Kibbelaar RE, Dalesio O, Kooistra A, Stam J, Meijer CJ, Wagenaar SS, Vanderschueren RG, van Zandijk N, Mooi WJ, Bos JL, Rodenhuis S (1990) K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 323:561–565

    Article  CAS  PubMed  Google Scholar 

  31. Slebos RJ, Hruban RH, Dalesio O, Mooi WJ, Offerhaus GL, Rodenhuis S (1990) Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung. J Natl Cancer Inst 83:1024–1027

    Article  Google Scholar 

  32. Sobin LH, Yesner R (1981) Histologic typing of lung tumors. International histologic classification of tumors. World Health Organization, Geneva

    Google Scholar 

  33. Venter DJ, Tuzi NL, Kumar S, Gullick WJ (1987) Overexpression of the c-erb-3 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification. Lancet 11:69–72

    Article  Google Scholar 

  34. Weinberg RA (1991) A short guide to oncogenes and tumor-suppressor genes. J NIH Res 3:45–48

    Google Scholar 

  35. Weiner DB, Nordberg J, Robinson R, Nowell PC, Gazdar A, Green MJ, Williams WV, Cohen JA, Kern JA (1990) Expression of the neu gene-encoded protein (p185neu) in human non-small cell carcinomas of the lung. Cancer Res 50:421–425

    CAS  PubMed  Google Scholar 

  36. Weynants P, Humblet Y, Canon JL, Symann M (1990) Biology of small cell lung cancer: an overview. Eur Resp J 3:699–714

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. III. Medizinische Klinik und Poliklinik Schwerpunkt Pneumologie, Klinikum der Johannes Gutenberg Universität Mainz, Langenbeckstrasse 1, D-55131, Mainz, Germany

    J. Lorenz, R. Paulus & R. Ferlinz

  2. Institut fur Toxikologie, Johannes Gutenberg Universität, Mainz, Germany

    T. Friedberg & F. Oesch

Authors
  1. J. Lorenz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Friedberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Paulus
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. Oesch
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Ferlinz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lorenz, J., Friedberg, T., Paulus, R. et al. Oncogene overexpression in non-small-cell lung cancer tissue prevalence and clinicopathological significance. Clin Investig 72, 156–163 (1994). https://doi.org/10.1007/BF00184595

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00184595

Key words

Search

Navigation